Spellman David A
Insider CIK 1733204 · MRSN Chief Financial Officer · AKBA SVP, CFO and Treasurer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AKBA Akebia Therapeutics, Inc. | S Sale | 2023-05-16 | 2023-05-18 | 63,567 | $1.07 | $68.0K | 446,483 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2023-03-01 | 2023-03-03 | 810 | $0.88 | $713 | 510,050 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2023-03-01 | 2023-03-03 | 6,400 | $0.88 | $5.6K | 510,860 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2023-02-27 | 2023-03-01 | 7,539 | $0.81 | $6.1K | 517,260 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2023-01-31 | 2023-02-02 | 294,300 | — | $0 | 294,300 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2023-01-31 | 2023-02-02 | 196,200 | — | $0 | 524,799 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2022-06-08 | 2022-06-10 | 200,000 | — | $0 | 200,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2022-06-08 | 2022-06-10 | 200,000 | — | $0 | 328,599 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2022-03-01 | 2022-03-02 | 803 | $2.17 | $1.7K | 128,599 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2022-02-28 | 2022-03-02 | 225,000 | — | $0 | 225,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2022-02-28 | 2022-03-02 | 60,000 | — | $0 | 129,402 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2022-02-28 | 2022-03-02 | 7,400 | $2.15 | $15.9K | 69,402 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2021-09-30 | 2021-10-01 | 200,000 | — | $0 | 200,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2021-04-01 | 2021-04-01 | 790 | $3.40 | $2.7K | 76,802 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2021-03-16 | 2021-03-18 | 7,592 | — | $0 | 77,592 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2021-02-26 | 2021-03-02 | 120,000 | — | $0 | 120,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2021-02-26 | 2021-03-02 | 70,000 | — | $0 | 70,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2020-06-30 | 2020-07-02 | 280,000 | — | $0 | 280,000 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2019-01-23 | 2019-01-25 | 100,000 | — | $0 | 100,000 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2018-03-12 | 2018-03-14 | 150,000 | — | $0 | 150,000 | SEC↗ |